Detalhe da pesquisa
1.
Abnormal metaphase cytogenetics predicts venous thromboembolism in myeloma: derivation and validation of the PRISM score.
Blood
; 140(23): 2443-2450, 2022 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35772005
2.
The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma.
Haematologica
; 109(3): 906-914, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646658
3.
Thromboprophylaxis in multiple myeloma: a case-based review with practical guidelines.
Ann Hematol
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630132
4.
How do we image patients with multiple myeloma and precursor states?
Br J Haematol
; 203(4): 536-545, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37217164
5.
The promise and harms of screening for plasma cell dyscrasias.
Br J Haematol
; 200(6): 704-707, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36626939
6.
First report of outcomes in patients with stage IIIb AL amyloidosis treated with Dara-VCD front-line therapy.
Br J Haematol
; 201(5): 913-916, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36896578
7.
Recommendations on prevention of infections during chimeric antigen receptor T-cell and bispecific antibody therapy in multiple myeloma.
Br J Haematol
; 203(5): 736-746, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37287117
8.
Cancer-specific mortality in multiple myeloma: a population-based retrospective cohort study.
Haematologica
; 108(12): 3384-3391, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439357
9.
Attrition and withdrawal in multiple myeloma randomized controlled trials: A systematic review.
Eur J Haematol
; 111(3): 491-498, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37382045
10.
Impact of autologous transplantation on survival in patients with newly diagnosed multiple myeloma who have high-risk cytogenetics: A meta-analysis of randomized controlled trials.
Cancer
; 128(12): 2288-2297, 2022 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35377484
11.
How do we manage t(11;14) plasma cell disorders with venetoclax?
Br J Haematol
; 199(1): 31-39, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35594184
12.
Venous thromboembolism risk with contemporary lenalidomide-based regimens despite thromboprophylaxis in multiple myeloma: A systematic review and meta-analysis.
Cancer
; 126(8): 1640-1650, 2020 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31913498
13.
Real-world data on safety and efficacy of venetoclax-based regimens in relapsed/refractory t(11;14) multiple myeloma.
Br J Haematol
; 189(6): 1136-1140, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32012228
14.
Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma.
Br J Haematol
; 189(6): 1074-1082, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32108328
15.
Novel prognostic scoring system for autologous hematopoietic cell transplantation in multiple myeloma.
Br J Haematol
; 191(3): 442-452, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33094839
16.
Risk of kidney toxicity with carfilzomib in multiple myeloma: a meta-analysis of randomized controlled trials.
Ann Hematol
; 99(6): 1265-1271, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32382772
17.
Emerging drugs for the treatment of light chain amyloidosis.
Expert Opin Emerg Drugs
; 25(3): 299-317, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32731778
18.
Treatment and disease-related complications in multiple myeloma: Implications for survivorship.
Am J Hematol
; 95(6): 672-690, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32086970
19.
Patient-Reported Outcomes with Chimeric Antigen Receptor T Cell Therapy: Challenges and Opportunities.
Biol Blood Marrow Transplant
; 25(5): e155-e162, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30500439
20.
The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment.
Blood
; 129(1): 82-87, 2017 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27729322